Shares of European pharmaceutical companies sold off on Friday after President Donald Trump issued letters to 17 companies, ...

The Trump administration has proposed a pilot initiative to address controversy over the 340B drug discount program.

Johnson & Johnson (NYSE:JNJ) has a sizable and broadly positioned operation, with strong representation in both the medical ...

Teva Pharmaceutical Industries TEVA reported second-quarter 2025 adjusted earnings of 66 cents per share, which beat the ...

US President Trump imposed 200% tariff on pharmaceuticals affecting US drug prices and supply chain, but analysts say it may not happen soon.

President Donald Trump sent letters to 17 leading pharmaceutical manufacturers, including Eli Lilly (NYSE:LLY), Pfizer ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

In the first quarter, Kathleen S. Wright Associates Inc. slashed its stake in Johnson & Johnson by a hefty 21.1%, unloading 1 ...

SINGAPORE (Reuters) -Shares of European drugmakers slipped on Friday after U.S. President Donald Trump sent letters to major ...

President Donald Trump sent letters to the leaders of 17 major pharmaceutical companies outlining how they should slash U.S.

Investing.com - Shares of European drugmakers fell on Friday after President Donald Trump issued letters to more than a dozen ...